IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out, sending stock down 69%

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

Jan 10, 2025 - 03:30
 0  1
IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out, sending stock down 69%
IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot